News

Zepbound beats Wegovy for weight loss

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across the U.
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both groups, the authors noted. As participants in both groups lost more ...
First head-to-head trial found Zepbound beats Wegovy for weight loss
Another interesting finding was that women in both ... clearly led to more weight loss in this trial. But it’s worth mentioning that when Wegovy was tested at a much higher dose of 7.2 ...
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.
Zepbound beats Wegovy for weight loss: Study
Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head clinical trial, according to findings published in The New England Journal of Medicine and presented at the European Congress on Obesity.
Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy
The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.
Today3d
Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer
A new study published in the New England Journal of Medicine comparing Eli Lilly’s Zepbound to Novo Nordisk’s Wegovy ... to get a higher yield when it comes to weight loss,” Azar explained.
Healio3d
Tirzepatide bests semaglutide for weight loss in adults with obesity
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks ... 10% or 15% of their body weight than those using semaglutide (Wegovy, Novo Nordisk). Similar findings ...
CBS News3d
Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs
The statement also said, in part, that "robust data" supporting Wegovy's "meaningful and unique benefits continue to grow" and that in addition to "offering significant and sustained weight loss ...
Verywell Health on MSN2d
Could Wegovy Cause Hair Loss?
People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...